“Medical Marijuana Competitive Intelligence Analysis, 2019” report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Medical Marijuana industry. A detailed picture of the competitive landscape is provided with summation of data from multiple sources with complete analysis of companies, patents, pipeline products, competitive benchmarking and therapeutic assessment of clinical products.
Key Market Drivers
- Growing legalization of medical marijuana
- Rising research and development activities
- Increasing ageing population
Scope of the report:
- Provides an overview of therapeutic pipeline activity for medical marijuana across the clinical product development cycle including phase I, phase II and phase III stages.
- It comprises of detailed profiles of companies active in medical marijuana arena with key coverage of business overview, products, and latest development activities focusing on collaborations and licensing deals, partnerships and agreements, acquisitions, product launches, awards and grants, and other latest developments.
- It comprises of analysis of medical marijuana pipeline products with key coverage of brief drug description and product profile focusing on molecule type, phase of clinical development, drug developer, indication, and route of administration.
- Therapeutic assessment of the active pipeline products by stage, indication, and route of administration.
- Provides information about drivers, barriers and opportunities that are shaping the medical marijuana market.
- Covers CI analysis consisting of comprehensive SWOT and PESTEL analysis.
- Provides list of “Medical Marijuana” patents filed in the last five years.
- Presents comments of experts and latest updated in the medical marijuana field, including industry updates, product launches, and scientific intelligence.
2. Legality of Medical Marijuana
3. Market Dynamics
4. CI Analysis
5. Market Scenario
6. Company Profiling
7. Competitive Benchmarking
8. Therapeutic Assessment: Clinical Products
9. Pipeline Analysis
9.1. Caumz (PPP011): Tetra Bio-Pharma
9.2. Medical Cannabis: MedReleaf
9.3. Lenabasum: Corbus Pharmaceuticals
9.4. BX-1: Bionorica SE
9.5. Cannabis oil: TO Pharmaceuticals
9.6. THX-110: Therapix Biosciences
9.7. Olorinab: Arena Pharmaceuticals
9.8. VSN16R: Canbex Therapeutics
9.9. Dronabinol: Daisy Pharma Opioid Venture
9.10. TN-TC11G: Tilray
10. Approved Drugs
10.1. Epidiolex: GW Pharmaceuticals
10.2. Sativex: GW Pharmaceuticals
10.3. Cesamet: Valeant Pharmaceuticals
11. Patent Overview
12. Latest Updates
13. Experts Comments
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States